Home Blog Page 2488

3Shape Announces Leadership Transition: Rune Fisker Appointed External Executive Advisor to CEO After 25 Years of Pioneering Innovation

COPENHAGEN, Denmark, Sept. 12, 2025 /PRNewswire/ — 3Shape today announced a leadership transition that honors one of its most influential innovators. After 25 years at the forefront of 3Shape’s journey, Rune Fisker, Senior Vice President of Product Strategy, will step down from his current role and transition into a new position as External Executive Advisor to CEO Jacob Paulsen.

Since joining 3Shape at its earliest stages, Rune has been synonymous with innovation, vision, and growth. From laying the foundation of 3Shape’s groundbreaking scanner development to driving the company’s product organization and championing digital dentistry worldwide, Rune’s impact on the industry is unparalleled.

“Rune’s dedication, energy, and relentless pursuit of innovation have been invaluable in building 3Shape into the global market leader it is today,” said Jacob Paulsen, CEO, 3Shape. “We are delighted that Rune will continue to contribute in his new capacity, working directly with me to guide our next chapter.”

As part of this transition, 3Shape has initiated the recruitment of a new Senior Vice President of Product Strategy. The new leader will join the Senior Leadership Team and report directly to the CEO, ensuring continuity and renewed momentum in executing the company’s ambitious strategy. In the interim, Niclas Blohm, CTO, will serve as acting lead for the Product Strategy group.

Rune’s new role as External Executive Advisor reflects both his extraordinary legacy and his continued importance to 3Shape’s future. While he will step away from day-to-day management, Rune remains deeply connected to the company’s mission, supporting 3Shape’s ongoing drive to transform dentistry through innovation.

Contact:
Jessica O’Sullivan-Munck

Director & Head of Corporate Communicationsjessica.osullivanmunck@3shape.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/3shape/r/3shape-announces-leadership-transition–rune-fisker-appointed-external-executive-advisor-to-ceo-afte,c4233346

The following files are available for download:

 

KPLASS Recognised at Osaka World Expo 2025 for Breakthrough Far-Infrared Cough Relief Patch

Develops Far-Infrared patches supporting natural and non-invasive wellness.


KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 12 September 2025 – KPLASS, a manufacturer and brand of Far Infrared Technology patches, has received several awards at the Osaka World Expo 2025 namely the “Special Honour Product”, “Innovative Product Award”, “Distinguished Manufacturer Award” and “Outstanding Contribution Award”. Its Far Infrared Cough Relief Patch is available to consumers across Southeast Asia, including Malaysia, Singapore, Vietnam, Cambodia, and other markets. This recognition marks a notable milestone as KPLASS continues to expand in the region.

The KPLASS Far Infrared Cough Relief Patch uses Far Infrared Technology combined with targeted acupoint stimulation. Unlike conventional heat pads that provide surface warmth, Far Infrared rays penetrate deeper layers of the skin and help in blood circulation and other bodily functions. When applied to acupoints such as TianTu and DanZhong, the patch is activated to emit gentle heat through the acupoints that could improve blood flow, reduce inflammation and provide relief from cough symptoms through a non-invasive method.

“This recognition at the Osaka World Expo highlights our ongoing efforts in health and wellness innovation. By combining Far Infrared Technology with acupoint therapy, we aim to offer patches that are safe and effective for a wide range of users. We continue to focus on broadening access across Asia Pacific.” said Michael Hu, Founder and CEO of KPLASS Singapore.

The KPLASS range includes the Far Infrared Adult Cough Relief Patch, as well as a Far Infrared Child Cough Relief Patch intended for children aged 3 months to 6 years. Additional products in the range target pain relief, joint pain relief, and menstrual relief. These patches are designed to complement the body’s natural processes and provide non-invasive support.

KPLASS’s regional presence is growing in response to increased consumer interest in natural and technology-assisted health products, particularly in Malaysia. Plans are currently underway to introduce the Child Cough Relief Patch to the Malaysian market, complementing the existing adult range already available nationwide. In Singapore, KPLASS was named “Best Selling Cough Patch” by Watsons in 2022, 2024, and 2025, while the Child Cough Relief Patch continues to gain traction.

KPLASS relief patches are available in Malaysia at Watsons, Guardian, Alpro, AA Pharmacy, Multicare, Healthlane, Pillbox stores and other pharmacies nationwide. For more information, please visit www.kplass.sg, or follow KPLASS on Instagram and Facebook for the latest updates.

Image can be downloaded from this link – [Click Here].

Hashtag: #KPLASS #FarInfrared #Technology #Health



The issuer is solely responsible for the content of this announcement.

About KPLASS

KPLASS is a Singapore brand using leading edge of technology and healthcare innovation to alleviate daily body discomforts. It uses the Far Infrared technology, which is natural, safe and effective that helps to relieve the cough symptoms and various body pains. Backed by 25 years of R&D and manufacturing competency of its parent company, the marketing and offering are differentiated by combined Infrared technology and TCM Acupoints in everyday health care solutions that is drug free, non-invasive and thus convenient and user-friendly. Bring home the Infrared treatment at your comfort and convenience.

Back in Business: How Tourists Are Reviving Laos’ Hotels, Restaurants, Communities

Lao's nature (Photo: Rainforest Cruises)

After years of pandemic-induced quiet, Laos is seeing its hotels fill up, restaurants reopen, and communities come back to life, thanks to a new wave of returning international tourists.

Nexus Aesthetic Clinic Founder Dr. Samantha Tay Advocates for Enhanced Patient Safety in Aesthetic Medicine

Founder of Nexus Aesthetic Clinic addresses public concerns about injectables and highlights the importance of professional oversight.

SINGAPORE, Sept. 12, 2025 /PRNewswire/ — Amid a growing public conversation about the safety and efficacy of aesthetic procedures, Dr. Samantha Tay, founder of Nexus Aesthetic Clinic, is emphasizing the importance of prioritizing patient safety through direct, doctor-led care. By personally conducting all patient consultations and administering all injectable treatments, Dr. Tay aims to provide a transparent and reassuring experience for individuals seeking aesthetic enhancements.

The demand for non-surgical aesthetic treatments, such as those for reducing fine lines or improving skin texture, has risen significantly. With this increase in popularity comes a greater need for patient education and awareness about the critical role a qualified medical doctor plays in ensuring safe and appropriate outcomes.

“Patient education is the cornerstone of responsible aesthetic practice,” says Dr. Samantha Tay. “It’s vital that patients understand the nature of their treatment, the qualifications of their provider, and the importance of a thorough medical consultation. My approach is to ensure every patient feels fully informed and confident in their decision-making process, which should always prioritize their long-term well-being and health.”

At Nexus Aesthetic Clinic, Dr. Tay handles the entire patient journey, from the initial assessment of skin concerns like pigmentation and fine lines to the administration of treatments and post-procedure follow-up. This hands-on model ensures consistency of care and allows patients to build a trusted relationship with their medical provider. Dr. Tay’s extensive medical background and commitment to ongoing professional development further support the clinic’s focus on maintaining high standards of patient care.

By championing a practice model where a medical doctor is central to every step of the treatment process, Nexus Aesthetic Clinic reinforces a message of safety, professionalism, and informed patient choice in the aesthetics field.

ABOUT US

Nexus Aesthetic Clinic is a Singapore-based medical aesthetic clinic founded by Dr. Samantha Tay, dedicated to providing evidence-based, non-surgical aesthetic treatments. With a strong focus on safety, professionalism, and minimal downtime, the clinic offers personalised solutions to help patients achieve their desired beauty and wellness goals. Visit their website today at nexusaestheticsg.com

Media Contact:

Name:

Samantha Tay

Email:

iamdrsamantha@gmail.com 

Organization:

Nexus Aesthetic Clinic Pte Ltd

Address:

111 Somerset #03-19 Singapore 238164

Phone:

6979 8860

Website:

nexusaestheticsg.com

Company logo:

https://nexusaestheticsg.com/wp-content/uploads/2021/12/NEXUS_LOGO-1@0.5x.png

 

Global Report puts Evidence as Heart of Better Philanthropy to Tackle Complexity

Tanoto Foundation presents findings at AVPN Global Conference


HONG KONG SAR – Media OutReach Newswire – 12 September 2025 – At a time when governments, development agencies, and NGOs strive to address complex social challenges, the necessity to demonstrate real, sustainable results has never been greater. To remain effective, philanthropy must move with purpose, not only to fund initiatives but also to embrace measurement and evidence as a compass for decision-making and meaningful social change. To help the philanthropic sector do good, better, Tanoto Foundation launched The Evidence Behind Better Philanthropy report at the AVPN Global Conference in Hong Kong.

The study, developed in partnership with the Centre for Evidence and Implementation (CEI), provides a first-of-its-kind comparative analysis of how leading global foundations practice monitoring, evaluation, and learning (MEL), a much-discussed but often elusive cornerstone of effective philanthropy. By combining in-depth interviews with foundation leaders and an extensive review of global practice, the report offers timely insights from some of the world’s most influential funders on how evidence is shaping strategy, guiding adaptation, and enabling more collaborative approaches to impact across diverse and complex contexts.

Benny Lee, CEO of Tanoto Foundation, said: “For philanthropy to do good, it must also do better, because today’s challenges are more complex and interconnected. At Tanoto Foundation, we see evidence not just as a tool for accountability, but as a compass for strategy. By embedding monitoring, evaluation, and learning at the heart of decision-making, we can steward resources more effectively and contribute to meaningful, lasting social change.”

The report identifies 10 key findings, clustered into three broad themes for the philanthropic sector:

1. Strategy and Decision-Making: Embedding evidence into strategy through integrated “SMEL” (Strategy, Monitoring, Evaluation, and Learning) ensures programmes are responsive and adaptive, reducing wasted resources and increasing policy effectiveness.

2. Culture and Capacity: A learning culture, backed by senior leadership and grantee capacity-building, enables funders and implementers to course-correct in real time – critical for large-scale reforms and systems change.

3. Tools and Ecosystem for Impact: Flexible evaluation methods, a focus on contribution over attribution, and strategic communication help funders, governments, and NGOs align their efforts and scale what works.

Murni Leo, Global Head of Measurement, Learning and Evaluation at Tanoto Foundation, added: “This study reflects our belief that learning should not stop at compliance, but drive continuous improvement. At Tanoto Foundation, we have embedded MEL into how we design programmes, test assumptions, and adapt in real time. By sharing global practices openly, we hope to encourage a culture of collaboration where funders and partners alike can strengthen their use of evidence. When the sea rises, all boats rise—and MEL is one way to lift the sector together.”

The report aims to support decision-makers across sectors to design more effective interventions, strengthen accountability, and collaborate for systemic change.

The full report is now available and can be downloaded via the Tanoto Foundation website.

Hashtag: #TanotoFoundation

The issuer is solely responsible for the content of this announcement.

About Tanoto Foundation

At Tanoto Foundation, we unlock human potential, help communities thrive, and create lasting impact. Founded in 1981 by Sukanto Tanoto and Tinah Bingei Tanoto, we are an independent family foundation that believes in providing every person with the opportunity to realize his or her full potential. To do so, we catalyse systems change in education and healthcare. Our approach is impact-first, collaborative, and evidence-based. We invest for the long term and strive to develop leaders who can drive sustained, positive outcomes.

More information is available at

KPLASS Singapore Awarded at Osaka World Expo 2025 for Innovation in Far-Infrared Cough Relief Patch

Develops Far-Infrared patches supporting natural and non-invasive wellness.


SINGAPORE – Media OutReach Newswire – 12 September 2025 – KPLASS, a manufacturer and brand of Far Infrared Technology patches, has received has received several awards at the Osaka World Expo 2025 namely the “Special Honour Product”, “Innovative Product Award”, “Distinguished Manufacturer Award” and “Outstanding Contribution Award”. Its Far Infrared Cough Relief Patch is available to consumers across Southeast Asia, including Malaysia, Singapore, Vietnam, Cambodia, and other markets. This recognition marks a notable milestone as KPLASS continues to expand in the region.

KPLASS Recognised at Osaka World Expo 2025 for Breakthrough Far-Infrared Cough Relief Patch
KPLASS Recognised at Osaka World Expo 2025 for Breakthrough Far-Infrared Cough Relief Patch

The KPLASS Far Infrared Cough Relief Patch uses Far Infrared Technology combined with targeted acupoint stimulation. Unlike conventional heat pads that provide surface warmth, Far Infrared rays penetrate deeper layers of the skin and help in blood circulation and other bodily functions. When applied to acupoints such as TianTu and DanZhong, the patch is activated to emit gentle heat through the acupoints that could improve blood flow, reduce inflammation and provide relief from cough symptoms through a non-invasive method.

“This recognition at the Osaka World Expo highlights our ongoing efforts in health and wellness innovation. By combining Far Infrared Technology with acupoint therapy, we aim to offer patches that are safe and effective for a wide range of users. We continue to focus on broadening access across Asia Pacific.” said Michael Hu, Founder and CEO of KPLASS Singapore.

The KPLASS range includes the Far Infrared Adult Cough Relief Patch as well as the Far Infrared Child Cough Relief Patch, designed for children aged 3 months to 6 years. Safe for both adults and young children, the patch offers a gentle yet effective alternative to traditional medication, suitable for use during the day or night. Additional products in the range target pain relief, joint pain relief, and menstrual relief, with each relief patch developed to work naturally with the body through a non-invasive approach.

KPLASS’s regional presence is growing in response to increased consumer interest in natural and technology-assisted health products. In Singapore, KPLASS was named “Best Selling Cough Patch” by Watsons in 2022, 2024, and 2025, with the Child Cough Relief Patch gaining steady traction among parents seeking safe, drug-free options for their families.

KPLASS relief patches are available at leading pharmacy chain like Guardian, Watsons and Unity and also online via Shopee and Lazada in Singapore. For more information, please visit www.kplass.sg, or follow KPLASS on Instagram and Facebook for the latest updates.
Hashtag: #KPLASS #FarInfrared #Technology #Health



The issuer is solely responsible for the content of this announcement.

About KPLASS

KPLASS is a Singapore brand using leading edge of technology and healthcare innovation to alleviate daily body discomforts. It uses the Far Infrared technology, which is natural, safe and effective that helps to relieve the cough symptoms and various body pains. Backed by 25 years of R&D and manufacturing competency of its parent company, the marketing and offering are differentiated by combined Infrared technology and TCM Acupoints in everyday health care solutions that is drug free, non-invasive and thus convenient and user-friendly. Bring home the Infrared treatment at your comfort and convenience.

22nd China-ASEAN Expo: AI in the Spotlight

NANNING, China, Sept. 12, 2025 /PRNewswire/ — A report from China Report ASEAN: The 22nd China-ASEAN Expo, will run from Sept 17 to 21. Blooming AI Hibiscus flowers at the Nanning International Convention and Exhibition Center and commencement of the “AI for All” Super League Competition in Guangxi Zhuang Autonomous Region signal the impending opening of the 22nd China-ASEAN Expo (CAEXPO) in Nanning.

An important open platform for China-ASEAN cooperation, CAEXPO has tightly embraced the new era of AI. For the first time, the entire process of expo organization has been empowered by large language models (LLMs). A new dedicated AI pavilion has been introduced. A large number of leading Chinese and foreign AI enterprises are dispatching representatives to the exhibitions and forums. And Diverse AI-themed activities will take place. Everything will contribute to the “never-ending” exchange and cooperation platform between China and ASEAN.

Participation of Leading AI Enterprises

The upcoming CAEXPO will feature a Special AI Pavilion with an exhibition area of 10,000 square meters for the first time. Some well-known Chinese AI enterprises have actively sought space at the expo. More than 100 enterprises including leading AI companies, unicorns, and start-up teams have confirmed participation. Many cutting-edge technologies and unrivaled products will be exhibited. Organizers are expecting to welcome Huawei’s latest HarmonyOS foldable PC and ultra-luxury smart car, Alibaba Cloud’s world-leading Tongyi model, an AI Stack all-in-one computer and an AI full-stack cloud, Unitree’s latest four-legged robot and humanoid robot, iFlytek’s latest Spark LLM, a multilingual intelligent customer service terminal, multi-scenario application solutions, Lingban Technology’s world’s first AI & AR Rokid glasses and OST spatial computing platform with gesture-based interaction, DJI’s latest aerial photography drones, handheld imaging equipment, and DJI RS 4 camera stabilizers. Several products are making a global debut at the expo. For example, the world’s first explosion-proof humanoid robot “Tiankui-1,” the world’s first full-size general-purpose humanoid robot, fire training simulator and tunnel rescue LLM, and the country’s first collaborative welding robot.

The ASEAN Zone at the dedicated AI pavilion has been warmly welcomed by ASEAN members. The Brunei Innovation Lab, Indonesian Telematics Society, Malaysian Global Telecom Group, Myanmar Computer Industry Association, and Thai Mitr Phol Group will participate in the ASEAN High-Tech Products Exhibition Area (AI Section) to showcase smart agriculture technologies, remote communication equipment, and scientific and technological innovation projects from ASEAN countries. Meanwhile, Vietnam’s Ministry of Science and Technology has been organizing Vietnamese enterprises to exhibit high-tech projects at the Vietnamese Commodities Pavilion.

During the upcoming CAEXPO, special exhibitions will take place at the China-ASEAN AI Innovation Cooperation Center (South A Center), and more than 10 supporting activities will be held including the China (Nanning) – ASEAN AI Scenario Application and Networking Exchange Conference. Heads of delegations from ASEAN countries, presidents of business associations, and well-known enterprises will visit the South A Center to promote establishment of a new cooperation model of “R&D in Beijing, Shanghai, and Guangzhou, integration in Guangxi, and application in ASEAN.”

Intelligent Expo Organization

Alongside the dedicated AI pavilion, other exhibition areas have been upgraded and with a focus on “AI+.” For example, the Financial Services Exhibition Area will showcase the latest digital and intelligent achievements in enhancing financial service capabilities through technologies such as AI, big data, and block chain. The Green and Intelligent Transportation and Engineering Equipment Exhibition Area will feature intelligent driving vehicles, digital and intelligent technology systems and solutions, and new energy commercial vehicles. The Smart Energy and Power Exhibition Area will showcase specialized AI chips meant for the power industry, virtual power plant intelligent aggregation platforms, and unmanned intelligent equipment technologies for the new energy sector.

The achievements of “AI+” in Guangxi will be exhibited collectively. For example, Nanning City will display its “AI for All,” Guilin City will display its “AI+cultural tourism,” Beihai City will display its “AI+cyber celebrity economy” and “Tourism Professional Competence Cognition Platform,” and Wuzhou City will display its “AI +fashion industry (artificial gem).”  

Diverse AI-Themed Activities

The CAEXPO will feature several AI-themed activities including the “Chinese AI Unicorn Global Expansion Night,” during which the “Top 100 Future Global AI Unicorns from China” will be released. An AI Industry Elites’ Dialogue Salon will be held for senior professionals and young scientists in the field of AI R&D and application to exchange views on the cutting-edge development trends of the industry. In the AI for All Week, exhibitions on the achievements and prospects of AI in promoting the intelligent upgrading of traditional industries and fostering the development of new quality productive forces will open. The China-ASEAN AI Innovation and Application Week will facilitate the establishment of a full industrial chain encompassing technology R&D, scenario application and ecosystem expansion, build a smart China-ASEAN culture and tourism cooperation platform, and promote cooperation in AI innovation.

Innovative Application of LLMs

CAEXPO is committed to creating a model for “AI+expo.” LLMs will play a significant role in multiple key scenarios at the expo including networking, communication, exhibition setup, and visits.

The core function of the LLMs is to draw “precise portraits” of exhibitors and purchasers. With analysis of both parties’ demands, product features, previous cooperation preferences, and predictions of new demands under the major trends of technology and industry, the LLMs can carry out smart networking, which is expected to significantly enhance the efficiency of networking on the spot.

An LLM that can translate multiple ASEAN languages will be deployed to help Chinese and ASEAN enterprises better bridge the information gap and overcome language barriers.

CAEXPO is also providing exhibitors with AIGC-powered booth design tools to simplify and streamline exhibition setup.

 

Prioritizing Quality and Patient Safety with Digital Transformation, RS Pondok Indah Group Becomes First in Indonesia to Achieve HIMSS EMRAM Stage 7

Setting new standards in healthcare quality and patient safety through digital transformation.

JAKARTA, Indonesia, Sept. 12, 2025 /PRNewswire/ — RS Pondok Indah Group (Pondok Indah Hospital Group) has made history as the first hospital group in Indonesia to achieve the HIMSS Electronic Medical Record Adoption Model (EMRAM) Stage 7, the world’s highest quality standard for assessing digital maturity and data management in hospitals. This recognition was awarded to all three hospitals under RS Pondok Indah Group—RS Pondok Indah – Pondok Indah, RS Pondok Indah – Puri Indah, and RS Pondok Indah – Bintaro Jaya—marking a major milestone in Indonesian healthcare.

The HIMSS surveyor team conducted an assessment of digital validations in patient medication administration based on patient medical history, blood transfusions, and expressed breast milk management, to ensure accuracy and enhance patient safety.
The HIMSS surveyor team conducted an assessment of digital validations in patient medication administration based on patient medical history, blood transfusions, and expressed breast milk management, to ensure accuracy and enhance patient safety.

Stage 7 reflects the group’s commitment to building a fully digital and paperless environment where patient safety, data security, and quality of care go hand in hand. The hospital has invested in secure and reliable systems to protect medical records, maintain confidentiality, and ensure uninterrupted access to information—even during unexpected disruptions.

According to dr. Yanwar Hadiyanto, MARS, Chief Executive Officer (CEO) of RS Pondok Indah Group, “This achievement represents our commitment to delivering the highest quality of care through comprehensive and continuous digitalization. By strengthening hospital information systems, integrating digital medical devices, and building secure infrastructure, we aim to optimize patient safety and service quality while empowering our medical teams with the updated knowledge and tools they need to make the best decisions.”

Safer Care through Automation and Standardization

A key milestone in this journey is the automation of vital signs recording and the direct connectivity of medical devices with the hospital information system. This automatically captures data into electronic medical records (EMRs) without manual input, reducing human error and improving accuracy.

Medical data is now recorded in a structured and standardized format, making it consistent, reliable, and always available. For doctors this strengthens treatment planning, while for patients it reduces errors and keeps data secure.

Engaging Patients in Their Own Care

Patient engagement has become a cornerstone of RS Pondok Indah Group’s digital transformation. The Smart Medical Broadcaster (SMB) which available in hospital rooms allows patients to access treatment history, lab results, and radiology reports. The same portal is available via the RSPI Mobile app and the hospital website, keeping patients connected even outside the hospital.

For dialysis patients, the group has introduced Patient-Reported Outcome Measures (PROM), which help doctors better understand patients’ quality of life and prescribe care more precisely. By tailoring therapy to each patient’s condition, PROM supports more personalized treatment and improved clinical outcomes.

The group has also simplified outpatient visits through a fully integrated digital journey. With a single QR code, patients can check in, see their doctor, and collect prescriptions in one seamless process. This implementation simplifies the patient journey into a faster, more convenient, and efficient experience.

Patient Safety as the Foundation of Digital Transformation

Beyond patient engagement, the Group has enhanced its clinical decision-making systems. A clinical decision support system, integrated with Computerized Practitioner Order Entry (CPOE), provides real-time alerts to guide doctors based on each patient’s condition, helping minimize risks and ensure safer care.

Digital validation processes have also been implemented for medication administration, blood transfusions, and expressed breast milk. These safety measures confirm that the right treatment reaches the right patient, preventing potentially dangerous errors. Together, these measures demonstrate how technology is embedded in daily care to strengthen accuracy and patient safety.

Imam Daru Nurwijayanto, Chief Information Technology Officer of RS Pondok Indah Group, explained, “We are expanding integration across devices, applications, and external systems to improve clinical and administrative operations. This also enhances our ability to use data for better decisions. Above all, every system is designed with a patient-centric approach—relevant, easy to use, and effective in improving care. The goal is a smoother patient journey and, most importantly, improved patient safety.

Building a Lasting Digital Culture

The HIMSS EMRAM Stage 7 achievement is more than a certification—it proves that digitalization has become part of RS Pondok Indah Group’s culture. Technology is now an essential element of daily practice, embraced by doctors, nurses, and staff across the organization.

“This milestone motivates us to continue our digital transformation,” added dr. Yanwar. “With a strong digital foundation, we will keep innovating to provide care that is safe, high-quality, internationally accredited, and consistently patient-focused, and strengthen our role as a trusted healthcare leader in Indonesia.”

About RS Pondok Indah Group

RS Pondok Indah Group is a private hospital group that manages three hospitals in Indonesia (RS Pondok Indah– Pondok Indah, RS Pondok Indah – Puri Indah and RS Pondok Indah – Bintaro Jaya) that provide leading-edge health services by prioritizing quality and patient safety. RS Pondok Indah Group is supported by hundreds of competent and professional medical personnel by utilizing medical technology and digital hospital information systems, in order to provide excellent health services.

The three hospitals within the RS Pondok Indah Group have been fully accredited by KARS (Hospital Accreditation Committee) and received international standard accreditation from the Joint Commission International (JCI). The three hospitals of RS Pondok Indah Group became the first three hospitals in Indonesia to achieve Stage 7 HIMSS EMRAM validation in August 2025.